KD virus compared to control virus (t(8)=-3.445, p=0.009). (C) Open-field test for mice injected with miR-15a KD virus relative to control (n=11, 12). The mice spent significantly less time in the center of the arena (F(1,22) =5.27, p=0.032) . No changes were observed in the distance spent in center or visits to center. (D) Open-field test for mice injected with miR-15a KD or control viruses (n=10, 9) and were also subjected to social defeat. There were no differences in the time the mice spent in the center of the arena but they showed a tendency to travel less distance in the center of the arena (U=22, p=0.060) and had fewer visits to the center of the arena (U=20, p=0.041).
Supplemental Materials and Methods (related to Experimental Procedures)

Animals
C57BL/6J mice and ICR mice (outbred mice strain, also known as CD1) (Harlan Israel, Kiryat Weizmann, Rehovot) were maintained in a pathogen-free temperature-controlled (22 ± 1°C) mouse facility on a reverse 12 h light-dark cycle at the Weizmann Institute of Science, according to institutional guidelines. Food (Harlan Israel, Kiryat Weizmann, Rehovot) and water were given ad libitum. C57BL/6J mice were housed 4 per cage whereas ICR mice were single caged. The total number of animals used for the Ago2 IP was 30 (18 social defeat and 12 controls). The total number of animals used for the lentiviruses experiment was 40 in total (10 per group).
Chronic social defeat
10-week old C57BL/6J male mice were subjected to a social defeat protocol as previously described (Krishnan et al. 2007) . Briefly, the mice were placed randomly in a home cage of an aggressive ICR mouse and allowed to physically interact for five minutes. During this time, the ICR mouse attacked the intruder mouse and the intruder displayed subordinate posturing. A perforated clear Plexiglas® divider was then placed between the animals and the mice remained in the same cage for 24 h to allow sensory contact. The procedure was then repeated with an unfamiliar ICR mouse for each of the 10 consecutive days. Control mice were housed in the same room as the social defeat mice but were taken out of the room during the five-minute interaction with the ICR.
Control mice were handled daily and housed 2 per cage with a perforated clear Plexiglas® divider placed between the 2 mice. The cage used for the social defeat is a type II long cage for mice (W x D x H) 15.59 x 8.46 x 6.77 inch. The bedding used during the social defeat was Aspen Sami bedding 17304. Mice were not lethally injured although superficial marks were observed. We find that within a period of 5 minutes the mice tend to avoid major injuries.
Microdissection of brain sites for Ago2 IP
Amygdala samples were collected from social defeat and control mice 8 days after the end of the chronic social defeat protocol. Tissue collection and processing was performed as previously described (Lebow et al., 2012; Sztainberg et al., 2010) . Briefly, after removing the brain and placing it on an acryl 1 mm brain matrix (Stoelting Co., Wood Dale, IL, cat# 51380), 2 mm slices were taken using standard razor blades (GEM, 62-0165) based on designated anatomical markers. Blunted syringes of different diameters were used to punch out the amygdala from slices removed from the matrix.
Immunoprecipitation of Ago2 protein
Pools of 3 amygdalae taken from 3 mice from the same treatment group (either Social defeat n=18 or Control n=12) were homogenized in NP40 buffer, which was supplemented with RNase inhibitor, protease inhibitor and phosphatase inhibitor (Roche Diagnostics, Indianapolis, IN). The samples were constantly agitated for 2 h at 4°C.
Samples were then centrifuged for 20 min at 12,000 rpm at 4°C in a microcentrifuge; the supernatant was placed in a fresh tube, kept on ice and the pellet was discarded.
Magnetic protein G beads (Dynabeads, Invitrogen Life Technologies, Carlsbad, CA) were incubated with the Ago2 monoclonal antibody (WAKO chemicals GmbH, Neuss, Germany) with rotation at room temperature for 10 minutes. After several washes, the samples were added to the Ago2-coated protein G beads and incubated overnight at 4°C under agitation. The following day the beads were washed 3 times with PBS. For RNA purification, the beads were homogenized in RLT buffer (RNeasy kit, QIAGEN, Hilden, Germany -miRNA supplementary protocol). For western blot analysis, the beads were boiled in sample buffer to release the protein from the beads.
RNA purification and microarray
RNA from the Ago2 immunoprecipitation samples was isolated using the RNeasy plus kit (QIAGEN, Hilden, Germany) following QIAGEN's supplementary Protocol 1:
Purification of total RNA containing miRNA. RNA for all other purposes was isolated from frozen brain punches using the miRNeasy mini kit (QIAGEN, Hilden, Germany) according to the manufacturer's recommendation. RNA derived from tissues of stressed mice following Ago2 immunoprecipitation was further analyzed on an Affymetrix miRNA 2.0 array (enriched RNA protocol) and an Affymetrix Mouse Gene 1.0 ST array (Affymetrix, Santa Clara, CA).
Microarray analysis
For the miRNA analysis, we used 4 arrays for the control mice and 6 arrays for the social defeat mice (each array consists of a pool of 3 mice). We used step up correction for multiple testing correction. The fold change threshold was 1.75 with a p value of p < 0.01. For the gene analysis, we used 3 arrays for the control mice and 6 arrays for the social defeat mice (each array consists of a pool of 3 mice). The fold change threshold was 1.3 with a p value of p < 0.05.
Bioinformatic analysis of microRNA microarray results
miRNAs and genes were tested in 3 different web based programs in search for a seed match between a miRNA and a 3'-UTR: Target Scan (http://www.targetscan.org), Miranda (http://www.microrna.org), (Betel et al., 2008) and Pictar (http://pictar.mdcberlin.de).
Cloning of 3'-UTRs into Psicheck2 luciferase expression plasmid
The 3'-UTR sequence of FKBP51 was PCR amplified from mouse genomic DNA using a forward primer: CCAACTCAGGACTGAACAGT and a reverse primer:
GTTCCTTAGGCTGTGGAGAA. The DNA sequence for the mutated form of FKBP51 was generated by site directed mutagenesis using the original cloning primers of Cloning orientation was verified by diagnostic cuts and sequencing.
Transfections and luciferase assay
Huh7 cells were grown on poly-L-lysine coated 48-well plates to 70-85% confluence and transfected using polyethylenimine with the following plasmids: 5 ng of Psicheck2-3'-UTR plasmid and 215 ng of EGFP over-expressing vector for either a specific miRNA, or a miR-scramble EGFP plasmid. 24 h following transfection, cells were lysed and luciferase reporter activity was assayed as previously described (Chen et al. 2005) .
Renilla luciferase values were normalized to control luciferase levels (transcribed from the same vector but not affected by the 3'-UTR tested) and averaged across eight-well repetitions per condition.
miRNA RT-qPCR expression analysis
Quantitative miRNA expression was acquired and analyzed using a step one thermocycler (Applied Biosystems, Waltham, MA), using miRCURY LNA Universal RT microRNA PCR primers (Exiqon, Vedbaek, Denmark) or miScript primer assay (QIAGEN, Hilden, Germany). RNA samples were assessed using miRCURY Universal cDNA Synthesis kit II and miRCURY ExiLENT SYBR Green (Exiqon, Vedbaek, Denmark) or miScript II RT kit and miScript SYBRgreen PCR kit (QIAGEN, Hilden, Germany), according to the manufacturer's guidelines. U6, 5S rRNA were used as internal controls. Gene expression was obtained using the High Capacity kit and SYBR green PCR master mix (Applied Biosystems, Waltham, MA). The real-time PCR primers for FKBP51 were: forward: ATGACTACTGATGAGGGCAC and reverse: GACATAAACTTTGTCACCAAAC.
Design, construction and validation of miR-15 lentiviruses
The miR-15a over-expression vector was cloned as follows: the enhanced form of human synapsin I promoter (Hioki et al. 2007) 
Stereotactic intracranial injections
A computer-guided stereotaxic instrument and a motorized nanoinjector (Angle Two TM Stereotaxic Instrument, myNeurolab, Leica Biosystems, Buffalo Grove, IL) were used as previously described (Elliott et al., 2010; Kuperman et al., 2010; Regev et al., 2012) . 10-week old male mice were randomly selected and anesthetized using 1.5% isoflurane and 1 μl of the lentiviral preparation was delivered to each BLA using a Hamilton syringe connected to a motorized nanoinjector system at a rate of 0.2 μl per min (coordinates relative to bregma: AP = -1.58 mm, L = ±3.3 mm, H = -4.6 mm). Following a 2-week recovery period, mice were subjected to behavioral studies and later anesthetized and perfused with 4% PFA. The fixed brains were serially sectioned and immunohistochemically stained in order to confirm the location of the injection site, as previously described (Regev et al., 2011) . The antibodies that were used were: Goat biotinylated anti-GFP (Abcam, Cambridge, UK; ab6658) and Alexa Fluor 488
Streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA; 016-540-084).
3 repetitions were used for the immunohistochemical analysis.
Behavioral assessments
All behavioral assessments were performed during the dark (active) phase following habituation to the test room for 2 hours before each test. Behavioral tests were conducted as previously described (Haramati et al., 2011; Lebow et al., 2012) in the following order, from the least stressful procedure to the most and ending with home cage locomotor testing: Open-field, EPM and home cage locomotion.
Open-field test:
The open-field test was performed in a 50 x 50 x 22 cm white box, lit to 120 lux. The mice were placed in the box for 10 minutes. Locomotion in the box was quantified using a video tracking system (VideoMot2; TSE Systems, Bad Homburg, Germany).
EPM test: This apparatus in this test is designed as a plus sign and contains 2 barrier
walls and 2 open arms. During the 5-minute test, which is performed in relative darkness (6 lux), the number of entries, the distance traveled and the time spent in the open arms is automatically scored using a video tracking system (VideoMot2, TSE Systems, Bad Homburg, Germany).
Homecage locomotion: Homecage locomotion was assessed using the InfraMot system (TSE Systems, Bad Homburg, Germany). Mice were housed individually for 72 h, in which the first 24 h were considered habituation to the individual housing conditions.
Measurements of general locomotion consisted of 2 light and 2 dark cycles in the last 48 h, collected at 10 min intervals.
Statistics
Data are expressed as mean ± standard error of the mean (Binder et al.) . Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) software (SPSS Inc., Chicago, IL). All data sets' distributions were tested for normality using Shapiro-Wilks test in order to determine which statistical tests should be applied.
In cases where indices of 2 groups were compared and the data's distribution was normal, a 2-sided students t-test was used, where the data departed from normal distribution, the Mann-Whitney U test was applied. All data sets were also tested for variance similarity between compared groups. For the miRNA array results, a q-value correction was performed. Mice were excluded from the analysis if they had values higher than AVG+2*SD or lower than AVG-2*SD
Human studies -qPCR analysis
Samples: For this study, 26 males of Caucasian origin aged between 19 and 30 years were recruited (mean age = 25.58 +/-2.64SD). All participants were free of a history of psychiatric disorders as well as major neurological and general medical disorders.
Further exclusion criteria were regular use of medical drugs, as well as excessive alcohol or caffeine consumption. All subjects gave written informed consent. Procedures were approved by the Ethics Committee of the Ludwig Maximilians University, Munich, Germany, in accordance with the Declaration of Helsinki.
Study Design: Unstimulated peripheral blood samples were drawn at 12:00pm followed by oral administration of 1.5 mg of dexamethasone. Subsequently stimulated samples were collected at 1:00pm, 3:00pm, 6:00pm, and at 11:00am the following day.
PAXgeneTM (QIAGEN, Hilden, Germany) whole blood RNA collection tubes were used at each time point for whole blood collection.
RNA extraction: Total RNA was extracted using the PAXgene Blood RNA Kit (PreAnalytiX, Hombrechtikon, Switzerland) with the QIAGEN method for column purification of nucleic acids (PreAnalytiX, Hombrechtikon, Switzerland) according to the manufacturer's instructions. For RNA quality and quantity, extracted samples were subsequently run on the Agilent 2200 TapeStation (Agilent Technologies, Santa Clara, CA). All samples had an RNA integrity number (RIN) ≥7.
Quantitative real time polymerase chain reaction: Total RNA was reverse transcribed using the miRCURY LNA™ Universal RT miRNA PCR cDNA synthesis kit (Exiqon, Vedbaek, Denmark). CDNA was diluted and mixed with the Exiqon microRNA LNA PCR primers as well as the Exiqon SYBR Green master mix and assayed in 10 µl reactions.
qPCR experiments were performed using the Roche 480 LightCycler system (Roche Applied Science, Roche Diagnostics, Indianapolis, IN) in 384-well plates. Each sample was run in technical triplicates. Normalization of the results was performed against SNORD38 using the delta Ct method.
Western blot analysis
Frozen brain samples were homogenized in RIPA buffer supplemented with proteinase inhibitors (Sigma-Aldrich, St. Louis, MO) and were incubated on ice for 10 min. After 10 min centrifugation, the supernatant was transferred to a new tube and sample buffer was added to the sample, which was then boiled for 5 min and placed on ice. The samples were separated in a 10% polyacrylamide gel electrophoresis. Transfer was performed using an assembly of nitrocellulose membrane and Whatman paper. ECL was added to the membrane which was then exposed to film.
Social avoidance test
The test is performed in an open field design with a small neighboring chamber that is chemistry to a depth of minimum 5Mio reads per sample (% >=Q30 higher then 96).
Fastq raw sequence reads were quality-checked using FASTQC* and reads between 15-40nt length containing the Illumina Small RNA Adapter selected and adaptertrimmed using Cutadapt*. Reads were aligned to miRbase v21 and normalized to counts per million using sRNAbench* (library mode using Bowtie*). Differential expressed microRNAs were queried using the Bioconductor -DESeq2 package* applying a minimum cut-off of 5 read counts in all samples.
Subjects exposed to early life trauma
Control subjects were available at the IRCCS Fatebenefratelli Institute, Brescia (Italy).
Individuals presenting a history of neurological disease, prior electro-convulsivant treatment, prior traumatic brain injury, or mental retardation (IQ<70) were excluded from the study. Written informed consent was obtained by participants after receiving a complete description of the study, which has received approval by the local ethics committee. The list of traumatic events includes loss of a biological parent due to death or separation for at least 6 months, including being taken into local authority care, severe physical, sexual abuse by a parental figure and neglect. Physical abuse includes incidents that meet at least 2 of the following criteria: a) the abuse consisted of being hit with a belt or stick, or being punched or kicked; b) the abuse resulted in an injury, including broken limbs, black eyes or bruising; and c) the perpetrator was considered to be out of control. Sexual abuse was defined as unwanted or illegal sexual experiences prior to age 17 years with any adult or an individual at least 5 years older than the recipient, not necessarily limited to the immediate family; moreover, these experiences have to meet at least 2 of the following criteria: a) the perpetrator was known to the individual; b) the perpetrator was a relative; c) the perpetrator lived in the same household; d) the unwanted sexual experience occurred more than once; e) the perpetrator touched the child's genitals; f) the perpetrator forced the child to touch the perpetrator's genitals; and g) the abuse involved sexual intercourse.
Neglect was defined in terms of parents' disinterest in material care (feeding and clothing), health, schoolwork and friendships. Neglect was quantified for both mother and father.
The most conservative cut-off points published by Bifulco et al. (2005) were used to dichotomise these responses into a yes/no answer. For this study, we performed miRNA analyses using qPCR in a group of 20 subjects who reported at least one type of abuse (physical abuse, sexual abuse, physical, parents separation or loss and neglect) and 20 subjects matched for age and gender with no history of early life stress (mean age ± SD: 38.1 ± 6.1 and 37.5 ± 6.7 respectively in the subjects with and without childhood trauma, p<0.05); percentage of females of 55% and of 54% respectively in the subjects with and without childhood trauma, p<0.05).
Blood samples were collected by using PaxGene Blood Tubes. After collection, blood samples were then kept at room temperature for 2 hours, then at -20°C for 2 days and then at -80°C until their processing.
miRNA isolation from the blood of subjects Total RNA was extracted from 2.5 mL of blood with the PAXGene Blood miRNA Kit (QIAGEN, CA, USA), designed for the simultaneous isolation of small and large RNAs;
RNA concentration and quality were assessed through a NanoDrop spectrophotometer (Thermo Scientific, MA, USA).
